ClinicalTrials.Veeva

Menu

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Interstitial Cystitis

Treatments

Genetic: bladder tissue of Interstitial Cystitis and normal bladder tissue

Study type

Observational

Funder types

Other

Identifiers

NCT03523559
2018-03-025

Details and patient eligibility

About

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Enrollment

14 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female aged 19 yrs or greater
  • Patients diagnosed with Hunner lesion in Interstitial cystitis and who is scheduled to undergo transurethral resection
  • Patients diagnosed with Bladder cancer and who is scheduled to undergo cystectomy

Exclusion criteria

  • Male and female under aged 20 yrs
  • A person whose area of bladder cancer is larger than that of the normal area
  • A person who is going to have a cystectomy after chemotherapy on bladder cancer

Trial design

14 participants in 2 patient groups

Interstitial Cystitis
Treatment:
Genetic: bladder tissue of Interstitial Cystitis and normal bladder tissue
normal
Treatment:
Genetic: bladder tissue of Interstitial Cystitis and normal bladder tissue

Trial contacts and locations

1

Loading...

Central trial contact

sangok park

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems